Department of Error (DOI:10.1016/S0140-6736(07)60306-7);Statins audit: wrong question, wrong conclusions

Lancet

Volumn 369, Issue 9562, 2007, Pages 640-

  Moon, James C ^a   Bogle, Richard G ^b   Minas, Rubin ^c  

^a UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

^c Medway PCT   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; SIMVASTATIN;

CARDIAC PATIENT; COST EFFECTIVENESS ANALYSIS; DRUG COST; DRUG SUBSTITUTION; HEART DISEASE; HUMAN; LETTER; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; UNITED KINGDOM;

EID: 33847209984     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(07)60563-7     Document Type: Erratum

References (5)

1. Butler R., and Wainright J. Cholesterol lowering in patients with CHD and metabolic syndrome. Lancet 369 (2007) 27
2. National Prescribing Centre campaign to increase low-cost statin prescribing. http://www.npc.co.uk/statins.htm (accessed Jan 17, 2007).
3. NHS better care, better value indicators for the West Midlands. http://www.productivity.nhs.uk/Form_PCT_4.1_Statin.aspx?period=2006-Q2 &report=p41&orgCode=5CN&email= (accessed Jan 17, 2007).
4. Brown B. Direct comparison of the A to Z and PROVE IT trials: a second chance to gain a first impression. Circulation 113 (2006) 1382-1384
5. University College London Hospitals. Guidelines on statin prescribing in the prevention of cardiovascular disease. http://www.uclh.nhs.uk/NR/rdonlyres/0A09D988-0CAB-4CFC-BB58-BEC5212F6D19 /34496/statinprescribingguidelines1.pdf (accessed Jan 17, 2007).